Literature DB >> 21299355

Theoretical aspects of autism: causes--a review.

Helen V Ratajczak1.   

Abstract

Autism, a member of the pervasive developmental disorders (PDDs), has been increasing dramatically since its description by Leo Kanner in 1943. First estimated to occur in 4 to 5 per 10,000 children, the incidence of autism is now 1 per 110 in the United States, and 1 per 64 in the United Kingdom, with similar incidences throughout the world. Searching information from 1943 to the present in PubMed and Ovid Medline databases, this review summarizes results that correlate the timing of changes in incidence with environmental changes. Autism could result from more than one cause, with different manifestations in different individuals that share common symptoms. Documented causes of autism include genetic mutations and/or deletions, viral infections, and encephalitis following vaccination. Therefore, autism is the result of genetic defects and/or inflammation of the brain. The inflammation could be caused by a defective placenta, immature blood-brain barrier, the immune response of the mother to infection while pregnant, a premature birth, encephalitis in the child after birth, or a toxic environment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21299355     DOI: 10.3109/1547691X.2010.545086

Source DB:  PubMed          Journal:  J Immunotoxicol        ISSN: 1547-691X            Impact factor:   3.000


  22 in total

1.  Disordered porphyrin metabolism: a potential biological marker for autism risk assessment.

Authors:  Nicholas J Heyer; Diana Echeverria; James S Woods
Journal:  Autism Res       Date:  2012-02-01       Impact factor: 5.216

2.  Pupil and salivary indicators of autonomic dysfunction in autism spectrum disorder.

Authors:  Christa J Anderson; John Colombo; Kathryn E Unruh
Journal:  Dev Psychobiol       Date:  2012-05-29       Impact factor: 3.038

3.  D-Cycloserine Ameliorates Autism-Like Deficits by Removing GluA2-Containing AMPA Receptors in a Valproic Acid-Induced Rat Model.

Authors:  Han-Fang Wu; Po See Chen; Ya-Ting Hsu; Chi-Wei Lee; Tzu-Feng Wang; Yi-Ju Chen; Hui-Ching Lin
Journal:  Mol Neurobiol       Date:  2017-07-21       Impact factor: 5.590

4.  A double-blind placebo controlled trial of Ginkgo biloba added to risperidone in patients with autistic disorders.

Authors:  Elmira Hasanzadeh; Mohammad-Reza Mohammadi; Ahmad Ghanizadeh; Shams-Ali Rezazadeh; Mina Tabrizi; Farzin Rezaei; Shahin Akhondzadeh
Journal:  Child Psychiatry Hum Dev       Date:  2012-10

5.  Human Embryonic Stem Cells in the Treatment of Autism: A Case Series.

Authors:  Geeta Shroff
Journal:  Innov Clin Neurosci       Date:  2017-04-01

Review 6.  Immune system gene dysregulation in autism and schizophrenia.

Authors:  Maximilian Michel; Martin J Schmidt; Karoly Mirnics
Journal:  Dev Neurobiol       Date:  2012-09-01       Impact factor: 3.964

7.  Alleviation of N-Methyl-D-Aspartate Receptor-Dependent Long-Term Depression via Regulation of the Glycogen Synthase Kinase-3β Pathway in the Amygdala of a Valproic Acid-Induced Animal Model of Autism.

Authors:  Han-Fang Wu; Po See Chen; Yi-Ju Chen; Chi-Wei Lee; I-Tuan Chen; Hui-Ching Lin
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

Review 8.  Immune dysregulation in autism spectrum disorder.

Authors:  Daniela Briceno Noriega; Huub F J Savelkoul
Journal:  Eur J Pediatr       Date:  2013-12-03       Impact factor: 3.183

Review 9.  What is autism?

Authors:  Priya Joon; Anil Kumar; Milind Parle
Journal:  Pharmacol Rep       Date:  2021-03-10       Impact factor: 3.024

10.  An ecological study on childhood autism.

Authors:  Sophie St-Hilaire; Victor O Ezike; Henrik Stryhn; Michael A Thomas
Journal:  Int J Health Geogr       Date:  2012-10-11       Impact factor: 3.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.